• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARL ZEISS MEDITEC AG (JENA) VISUMAX FEMTOSECOND LASER; FEMTOSECOND LASER SYSTEM FOR REFRACTIVE CORRECTION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARL ZEISS MEDITEC AG (JENA) VISUMAX FEMTOSECOND LASER; FEMTOSECOND LASER SYSTEM FOR REFRACTIVE CORRECTION Back to Search Results
Patient Problem Loss of Vision (2139)
Event Type  Injury  
Event Description
Doctor has a website that either state or suggest that the procedure of keratopigmentation is safe and proven, and i've learned that many of their patients have experienced issues after the surgery that the doctors are not addressing, nor warning them about it prior to the procedure.Some have even lost some of their eyesight due to this procedure.This specific doctor's site is called kerato nyc, and can be found with a simple web search.He is using the visumax system to create a tunnel above the iris in order to inject an unsafe, unproven dye to change the eye color.This tunnel creation with the visumax is intended for icr surgeries to introduce intracorneal rings to flatten the central cornea to correct low levels or myopia.Dr.(b)(6) instead uses these tunnels for the rings to insert a dye.Reference reports: mw5148268, mw5148269, mw5148270, mw5148271, mw5148272.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VISUMAX FEMTOSECOND LASER
Type of Device
FEMTOSECOND LASER SYSTEM FOR REFRACTIVE CORRECTION
Manufacturer (Section D)
CARL ZEISS MEDITEC AG (JENA)
MDR Report Key18191707
MDR Text Key328913183
Report NumberMW5148359
Device Sequence Number1
Product Code OTL
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 11/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/21/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Patient Sequence Number1
-
-